June 27, 2008

ALS Lithium Trial Under Way at 10 Sites

An MDA-supported trial of lithium carbonate in ALS (amyotrophic lateral sclerosis, or Lou Gehrig’s disease) is now open at 10 medical centers across the United States.

Lithium is usually used to treat bipolar disorder. Earlier this year, a small study in Italy suggested it might slow the progression of ALS.